Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mi2000 TICI Follow-up

NCT07902414 is registered in ClinicalTrials.gov with MED-EL Elektromedizinische Geräte GmbH as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07902414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Mi2000 TICI Follow-up
Lead sponsor
MED-EL Elektromedizinische Geräte GmbH
Phase
Observational
Overall status
Recruiting
Start date
November 11, 2026
Completion date
May 31, 2030
Enrollment
36 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cochlear implantation, hearing loss, binaural

Arms

As registered; 1 arm.

  • Mi2000 TICI UNICO recipients Cochlear Implantation

    Recipients of a MED-EL Mi2000 TICI UNICO in a previous clinical investigation.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Word Test in Quiet Pre-op to 36 months after first fitting

    Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes

Lead sponsor's other trials

MED-EL Elektromedizinische Geräte GmbH, most recent start first.

Similar trials

Same condition (Hearing Loss) and phase, most recent start first.